Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
1 Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany.
2 Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich, Munich, Germany.
3 Technische Universität München, 80333, Munich, Germany.
4 Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
5 Research Unit Analytical Pathology, Helmholtz Center Munich, 85764, Neuherberg, Germany.
6 Department of Chemistry, Indiana University, Bloomington, IN, USA.
7 Department of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
8 Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, Munich, Germany.
9 DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
10 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
11 Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
12 German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
13 Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich, Munich, Germany. [email protected].
14 German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany. [email protected].
15 Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany. [email protected].
16 German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany. [email protected].
17 Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany. [email protected].